Literature DB >> 24250296

Serum zinc values in children with congenital heart disease.

W E Sadoh1, A E Sadoh.   

Abstract

BACKGROUND: Some children with congenital heart diseases (CHD) may have increased pulmonary blood flow that causes recurrent bronchopneumonia and congestive heart failure. Serum zinc is reduced in children with pneumonia and patients on diuretics.
OBJECTIVE: To evaluate the serum zinc level of children with CHD and their controls without CHD.
METHOD: The subjects were 41 children with CHD confirmed on echocardiography recruited from a paediatric cardiology clinic in a tertiary centre in Nigeria. The controls were 41 children without CHD. Biodata and anthropometric measurements were taken. The serum zinc was determined using atomic absorption spectrophotometer method. RESULT: The mean difference in the serum zinc of the subjects 101.3 ± 21.6 µg/dl and controls 106.5 ± 18.3 µg/dl, was not significant, p = 0.351. The subjects with pneumonia had a lower mean serum zinc value 89.5 ± 15.0 µg/dl compared to those without pneumonia 103.9 ± 22.2 µg/dl, p = 0.006. The mean serum zinc values of the subjects on diuretic was not statistically different from those not on diuretic, p = 0.599.
CONCLUSION: The serum zinc levels of the subjects and controls were not significantly different. Children with CHD and pneumonia had significantly lower zinc level compared to those without pneumonia.

Entities:  

Keywords:  congenital heart disease; diuretic; pneumonia; zinc

Mesh:

Substances:

Year:  2013        PMID: 24250296      PMCID: PMC3824452          DOI: 10.4314/ahs.v13i3.12

Source DB:  PubMed          Journal:  Afr Health Sci        ISSN: 1680-6905            Impact factor:   0.927


  16 in total

1.  Renal excretory actions of furosemide, of hydrochlorothiazide and of the vasodilator flosequinan in healthy subjects.

Authors:  W P Leary; A J Reyes; R D Wynne; K van der Byl
Journal:  J Int Med Res       Date:  1990 Mar-Apr       Impact factor: 1.671

2.  Diuretics and zinc.

Authors:  A J Reyes; W P Leary; C J Lockett; L Alcocer
Journal:  S Afr Med J       Date:  1982-09-04

3.  Taste acuity and zinc metabolism in captopril-treated hypertensive male patients.

Authors:  D K Abu-Hamdan; H Desai; J Sondheimer; J Felicetta; S Mahajan; F McDonald
Journal:  Am J Hypertens       Date:  1988-07       Impact factor: 2.689

4.  Incidence of congenital heart disease in Nigerian children.

Authors:  B Gupta; A U Antia
Journal:  Br Heart J       Date:  1967-11

Review 5.  Potential contribution of maternal zinc supplementation during pregnancy to maternal and child survival.

Authors:  L E Caulfield; N Zavaleta; A H Shankar; M Merialdi
Journal:  Am J Clin Nutr       Date:  1998-08       Impact factor: 7.045

6.  Zinc and copper in congestive heart failure.

Authors:  F Atlihan; T Söylemezoğlu; A Gökçe; G Güvendik; O Satici
Journal:  Turk J Pediatr       Date:  1990 Jan-Mar       Impact factor: 0.552

Review 7.  Zinc deficiency. A public health problem?

Authors:  H H Sandstead
Journal:  Am J Dis Child       Date:  1991-08

8.  Urinary zinc excretion during treatment with different diuretics.

Authors:  P O Wester
Journal:  Acta Med Scand       Date:  1980

9.  Zinc supplementation in young children with acute diarrhea in India.

Authors:  S Sazawal; R E Black; M K Bhan; N Bhandari; A Sinha; S Jalla
Journal:  N Engl J Med       Date:  1995-09-28       Impact factor: 91.245

10.  Congenital heart disease: prevalence at livebirth. The Baltimore-Washington Infant Study.

Authors:  C Ferencz; J D Rubin; R J McCarter; J I Brenner; C A Neill; L W Perry; S I Hepner; J W Downing
Journal:  Am J Epidemiol       Date:  1985-01       Impact factor: 4.897

View more
  2 in total

1.  Non-communicable diseases are reaching epidemic proportions: evidence from low and middle income countries.

Authors:  James K Tumwine
Journal:  Afr Health Sci       Date:  2013-09       Impact factor: 0.927

Review 2.  A systematic review of trends and patterns of congenital heart disease in children in Nigeria from 1964-2015.

Authors:  Mohammed Abdulkadir; Zainab Abdulkadir
Journal:  Afr Health Sci       Date:  2016-06       Impact factor: 0.927

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.